ArticleDiabetology & metabolic syndrome2014

Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.

Cristina Nita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.